Fauna Bio Raises $9 Million to Expand Comparative Genomics Platform for Novel Target Discovery

EMERYVILLE, Calif.: EMERYVILLE, Calif., Sept. 21, 2021 /PRNewswire/ -- Fauna Bio, a biotechnology company leveraging animal genomics to improve human health, today announced it has raised $9 million in Seed funding led by LifeForce Capital, with participation from True Ventures, Boom Capital, Pacific 8 Ventures, BioMed Ventures, Vibe Capital and...

Click to view original post